News und Analysen
DGAP-News: DWS Q3: Third Consecutive Quarter of Net New Assets Marks Flow Turnaround - Cost-Income Ratio Well on Track for Full-Year Target
DGAP-News: DWS Q3: Third Consecutive Quarter of Net New Assets Marks Flow Turnaround - Cost-Income Ratio Well on Track for Full-Year Target
EQS-News: Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy
EQS-News: Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy
EQS-News: Q1 2024: DWS Generates Strong Net Inflows and Reaches New All-Time High for Assets under Management
EQS-News: Q1 2024: DWS Generates Strong Net Inflows and Reaches New All-Time High for Assets under Management
EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: DWS Returned to Net Inflows in 2023 Supported by all Three Pillars – Passive including Xtrackers, Active and Alternatives
EQS-News: DWS Returned to Net Inflows in 2023 Supported by all Three Pillars – Passive including Xtrackers, Active and Alternatives
EQS-Adhoc: DWS Group GmbH & Co. KGaA: DWS proposes payment of extraordinary dividend of EUR 4.00 per share
EQS-Adhoc: DWS Group GmbH & Co. KGaA: DWS proposes payment of extraordinary dividend of EUR 4.00 per share
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Oliver Behrens nominated for election as next Chairman of DWS Supervisory Board
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Oliver Behrens nominated for election as next Chairman of DWS Supervisory Board
EQS-News: Q3 2023: DWS Progresses with Continued Net Inflows and Stable Revenues in Challenging Market Environment
EQS-News: Q3 2023: DWS Progresses with Continued Net Inflows and Stable Revenues in Challenging Market Environment
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Q2 2023: DWS makes Good Progress with Higher Net Inflows and Profit
EQS-News: Q2 2023: DWS makes Good Progress with Higher Net Inflows and Profit
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQS-Adhoc: DWS Group GmbH & Co. KGaA: CFO Claire Peel to leave in late Q3 2023
EQS-Adhoc: DWS Group GmbH & Co. KGaA: CFO Claire Peel to leave in late Q3 2023
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Karl von Rohr to step down as DWS Chairman in October
EQS-Adhoc: DWS Group GmbH & Co. KGaA: Karl von Rohr to step down as DWS Chairman in October
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: DWS 2022: Solid Results and Increasing Management Fees in Extraordinarily Challenging Environment
EQS-News: DWS 2022: Solid Results and Increasing Management Fees in Extraordinarily Challenging Environment
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: DWS announces Strategic Ambition and Financial Targets for 2025
EQS-News: DWS announces Strategic Ambition and Financial Targets for 2025